Terms: = Breast cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
279 results:
1. Selective impact of alk and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer.
Bartoloni S; Pescatori S; Bianchi F; Cipolletti M; Acconcia F
Sci Rep; 2024 Apr; 14(1):8200. PubMed ID: 38589728
[TBL] [Abstract] [Full Text] [Related]
2. Risk factors for severe complications and salvage management in direct-to-implant immediate breast reconstruction: A retrospective study.
Zhu M; Mao J; Fang J; Chen D
Medicine (Baltimore); 2024 Mar; 103(10):e37365. PubMed ID: 38457600
[TBL] [Abstract] [Full Text] [Related]
3. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer.
Singh S; Saxena S; Sharma H; Paudel KR; Chakraborty A; MacLoughlin R; Oliver BG; Gupta G; Negi P; Singh SK; Dua K
Pathol Res Pract; 2024 Apr; 256():155222. PubMed ID: 38452582
[TBL] [Abstract] [Full Text] [Related]
4. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
Zheng Q; Yan H; He Y; Wang J; Zhang N; Huo L; Liu Y; Wang L; Xu L; Fan Z
Cancer; 2024 Apr; 130(S8):1513-1523. PubMed ID: 38427584
[TBL] [Abstract] [Full Text] [Related]
5. Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants.
Kim N; Cho WK; Park W; Lee JE; Nam SJ; Kim SW; Yu J; Chae BJ; Lee SK; Ryu JM; Ko ES; Kim H
Breast Cancer; 2024 May; 31(3):391-400. PubMed ID: 38368487
[TBL] [Abstract] [Full Text] [Related]
6. High-grade intraductal carcinoma of the parotid gland harboring CTNNA1::alk rearrangement: Changes in genetic status using genetic testing during treatment with an alk inhibitor.
Watanabe T; Honma Y; Yonemori K; Sunami K; Yoshimoto S; Mori T
Head Neck; 2024 Mar; 46(3):E26-E31. PubMed ID: 38018800
[TBL] [Abstract] [Full Text] [Related]
7. Machine learning applied in patient-reported outcome research-exploring symptoms in adjuvant treatment of breast cancer.
Pappot H; Björnsson BP; Krause O; Bæksted C; Bidstrup PE; Dalton SO; Johansen C; Knoop A; Vogelius I; Holländer-Mieritz C
Breast Cancer; 2024 Jan; 31(1):148-153. PubMed ID: 37940813
[TBL] [Abstract] [Full Text] [Related]
8. treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study.
Schiza A; Fredriksson I; Sund M; Valachis A
Breast Cancer Res Treat; 2024 Jan; 203(2):235-243. PubMed ID: 37812362
[TBL] [Abstract] [Full Text] [Related]
9. Epidemiological and therapeutic profiles of lung cancer patients in the Hokushin Region Japan: a retrospective hospital administrative database study.
Kobayashi T; Nishino Y; Takiguchi T; Kanda S; Otsuki K; Tanaka Y; Nakazawa Y; Ito KI; Hayashi R; Yasumoto K; Uramoto H; Hirono Y; Makino T; Nakada M; Yano S; Koizumi T
BMC Pulm Med; 2023 Sep; 23(1):322. PubMed ID: 37658334
[TBL] [Abstract] [Full Text] [Related]
10. Acalabrutinib as a novel hope for the treatment of breast and lung cancer: an in-silico proof of concept.
Khaparkhuntikar K; Maji I; Gupta SK; Mahajan S; Aalhate M; Sriram A; Gupta U; Guru SK; Kulkarni P; Singh PK
J Biomol Struct Dyn; 2024; 42(3):1469-1484. PubMed ID: 37272883
[TBL] [Abstract] [Full Text] [Related]
11. Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial.
Cao M; Lu H; Yan S; Pang H; Sun L; Li C; Chen X; Liu W; Hu J; Huang J; Xing Y; Zhang N; Chen Y; He T; Zhao D; Sun Y; Zhao L; Liu X; Cai L
BMC Cancer; 2023 May; 23(1):463. PubMed ID: 37208633
[TBL] [Abstract] [Full Text] [Related]
12. The safety and efficacy for the treatment of alectinib in a women with alk-positive lung cancer delivered a healthy male neonate throughout Pregnancy: A case report.
Shang M; Luo X; Wu J; Wang Z; Chen Q; Zhou Y
Lung Cancer; 2023 Jun; 180():107188. PubMed ID: 37087822
[TBL] [Abstract] [Full Text] [Related]
13. Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.
Hallemeier CL; Moughan J; Haddock MG; Herskovic AM; Minsky BD; Suntharalingam M; Zeitzer KL; Garg MK; Greenwald BD; Komaki RU; Puckett LL; Kim H; Lloyd S; Bush DA; Kim HE; Lad TE; Meyer JE; Okawara GS; Raben A; Schefter TE; Barker JL; Falkson CI; Videtic GMM; Jacob R; Winter KA; Crane CH
JAMA Netw Open; 2023 Apr; 6(4):e238504. PubMed ID: 37083668
[TBL] [Abstract] [Full Text] [Related]
14. Quantifying the value of older adult-specific clinical trials: Post-lumpectomy irradiation among older adults with early-stage breast cancer.
Lee W; Carlson JJ; Basu A; Veenstra D
J Geriatr Oncol; 2023 May; 14(4):101487. PubMed ID: 37075565
[TBL] [Abstract] [Full Text] [Related]
15. Computational screening and structural analysis of Gly201Arg and Gly201Asp missense mutations in human cyclin-dependent kinase 4 protein.
Thirumal Kumar D; Shaikh N; Bithia R; Karthick V; George Priya Doss C; Magesh R
Adv Protein Chem Struct Biol; 2023; 135():57-96. PubMed ID: 37061341
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathological Analysis and treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
Liu X; Gong C; Zhang J; Feng W; Guo Y; Sang Y; Wang C; Chen Y; Wang J; Yu L; Zhang X; Luo Z
Cancer Res Treat; 2023 Jul; 55(3):1001-1010. PubMed ID: 36915248
[TBL] [Abstract] [Full Text] [Related]
17. Association of Radiation and Procarbazine Dose With Risk of Colorectal cancer Among Survivors of Hodgkin Lymphoma.
Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
[TBL] [Abstract] [Full Text] [Related]
18. [Effects of adjuvant trastuzumab on long-term survival of T1N0M0 stage human epidermal growth factor receptor 2 positive breast cancer: a real-world study].
Sun TH; Lu ZN; Song HT; Sun G
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):101-107. PubMed ID: 36709127
[No Abstract] [Full Text] [Related]
19. Comparison of clinicopathological characteristics and response to neoadjuvant systemic therapy in patients with HER2-low-positive and HER2-zero breast cancer.
Shi W; Wan X; He J; Wang Y; Zhang W; Xu Y; Huang X; Chen R; Xu L; Zha X; Wang J
J Investig Med; 2023 Apr; 71(4):384-393. PubMed ID: 36655808
[TBL] [Abstract] [Full Text] [Related]
20. Recent Updates on Structural Aspects of alk Inhibitors as an Anticancer Agent.
Ayaz MS; Bhupal R; Sharma P; Sahu A; Singh P; Gupta GD; Asati V
Anticancer Agents Med Chem; 2023; 23(8):900-921. PubMed ID: 36627781
[TBL] [Abstract] [Full Text] [Related]
[Next]
